Approval of the drug would be a win for Lilly as it tries to maintain dominance over the GLP-1 market, where it has already overtaken rival company Novo Nordisk, manufacturer of Ozempic and Wegovy
Dosing & Reconstitution Guide Educational guide for reconstitution and weekly dosing Standard / Gradual Approach (1 mL = ~5.0 mg/mL) Frequency: Inject once weekly subcutaneously [1] [2]
Personalised approach to weight management As with any medical intervention, the response to weight loss medications can vary among individuals
AI models and laboratory software evaluate this triple mechanism across three distinct receptor targets
Complete a health assessment The first step is an online questionnaire covering your health history, current medications, and weight goals
Glucagon-Like Peptide-1 Infusion Suppresses Aldosterone Levels in Healthy Normal-Weight Individuals: Double-Blind, Placebo-Controlled Crossover Study